Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Hypofractionation for prostate cancer: a word of caution journalArticle 2016 Bossi, A.; Blanchard, P.
Quelles exigences pour qu'un biomarqueur puisse être un critère de substitution acceptable ? journalArticle 2016 Paoletti, X.; Rotolo, F.; Michiels, S.
Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma journalArticle 2016 Gorphe, P.; Matias, M.; Even, C.; Ferte, C.; Bidault, F.; Garcia, G.; Temam, S.; Nguyen, F.; Blanchard, P.; Tao, Y.; Janot, F.
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence journalArticle 2016 Ignatiadis, M.; Azim, H. A.; Desmedt, C.; Veys, I.; Larsimont, D.; Salgado, R.; Lyng, M. B.; Viale, G.; Leyland-Jones, B.; Giobbie-Hurder, A.; Kammler, R.; Dell'Orto, P.; Rothe, F.; Laios, I.; Ditzel, H. J.; Regan, M. M.; Piccart, M.; Michiels, S.; Sotiriou, C.
Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer journalArticle 2016 Chemama, S.; Bayar, M. A.; Lanoy, E.; Ammari, S.; Stoclin, A.; Goere, D.; Elias, D.; Raynard, B.; Antoun, S.
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents journalArticle 2016 Merlevede, J.; Droin, N.; Qin, T.; Meldi, K.; Yoshida, K.; Morabito, M.; Chautard, E.; Auboeuf, D.; Fenaux, P.; Braun, T.; Itzykson, R.; de Botton, S.; Quesnel, B.; Commes, T.; Jourdan, E.; Vainchenker, W.; Bernard, O.; Pata-Merci, N.; Solier, S.; Gayevskiy, V.; Dinger, M. E.; Cowley, M. J.; Selimoglu-Buet, D.; Meyer, V.; Artiguenave, F.; Deleuze, J. F.; Preudhomme, C.; Stratton, M. R.; Alexandrov, L. B.; Padron, E.; Ogawa, S.; Koscielny, S.; Figueroa, M.; Solary, E.
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials journalArticle 2016 Buyse, M.; Molenberghs, G.; Paoletti, X.; Oba, K.; Alonso, A.; Van der Elst, W.; Burzykowski, T.
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma journalArticle 2016 Regairaz, M.; Munier, F.; Sartelet, H.; Castaing, M.; Marty, V.; Renauleaud, C.; Doux, C.; Delbe, J.; Courty, J.; Fabre, M.; Ohta, S.; Vielh, P.; Michiels, S.; Valteau-Couanet, D.; Vassal, G.
Patients aged over 75 years enrolled in Phase I clinical trials: the Gustave Roussy experience journalArticle 2016 Helissey, C.; Biondani, P.; Roquet, F.; Lanoy, E.; Mir, O.; Varga, A.; Massard, C.; Gazzah, A.; Ribrag, V.; Bahleda, R.; Postel-Vinay, S.; Angevin, E.; Deutsch, E.; Soria, J. C.; Hollebecque, A.
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma journalArticle 2016 Regairaz, M.; Munier, F.; Sartelet, H.; Castaing, M.; Marty, V.; Renauleaud, C.; Doux, C.; Delbe, J.; Courty, J.; Fabre, M.; Ohta, S.; Vielh, P.; Michiels, S.; Valteau-Couanet, D.; Vassal, G.
Hypofractionation for prostate cancer: a word of caution journalArticle 2016 Bossi, A.; Blanchard, P.
New insights into the evaluation of randomized controlled trials for rare diseases over a long-term research horizon: a simulation study journalArticle 2016 Bayar, M. A.; Le Teuff, G.; Michiels, S.; Sargent, D. J.; Le Deley, M. C.
Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role? journalArticle 2016 Ou, D.; Levy, A.; Blanchard, P.; Nguyen, F.; Garberis, I.; Casiraghi, O.; Scoazec, J. Y.; Janot, F.; Temam, S.; Deutsch, E.; Tao, Y.
Impact of dermatologic adverse events induced by targeted therapies on quality of life journalArticle 2016 Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S.
The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic journalArticle 2016 Delaloge, S.; Bonastre, J.; Borget, I.; Garbay, J. R.; Fontenay, R.; Boinon, D.; Saghatchian, M.; Mathieu, M. C.; Mazouni, C.; Rivera, S.; Uzan, C.; Andre, F.; Dromain, C.; Boyer, B.; Pistilli, B.; Azoulay, S.; Rimareix, F.; Bayou el, H.; Sarfati, B.; Caron, H.; Ghouadni, A.; Leymarie, N.; Canale, S.; Mons, M.; Arfi-Rouche, J.; Arnedos, M.; Suciu, V.; Vielh, P.; Balleyguier, C.
Incorporation of nested frailties into semiparametric multi-state models journalArticle 2016 Rotolo, F.; Rondeau, V.; Legrand, C.
Comment on "Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: a Bayesian network meta-analysis", published in Eur J Cancer 51 (2015), 1570-1579 journalArticle 2016 Blanchard, P.; Ribassin-Majed, L.; Lee, A.; Pignon, J. P.
Busulfan-melphalan in high-risk neuroblastoma: the 30-year experience of a single institution journalArticle 2016 Proust-Houdemont, S.; Pasqualini, C.; Blanchard, P.; Dufour, C.; Benhamou, E.; Goma, G.; Semeraro, M.; Raquin, M. A.; Hartmann, O.; Valteau-Couanet, D.
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial journalArticle 2016 Krol, A.; Ferrer, L.; Pignon, J. P.; Proust-Lima, C.; Ducreux, M.; Bouche, O.; Michiels, S.; Rondeau, V.
Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients journalArticle 2016 Barral, M.; Auperin, A.; Hakime, A.; Cartier, V.; Tacher, V.; Otmezguine, Y.; Tselikas, L.; de Baere, T.; Deschamps, F.
Innovations for phase I dose-finding designs in pediatric oncology clinical trials journalArticle 2016 Doussau, A.; Geoerger, B.; Jimenez, I.; Paoletti, X.
Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes journalArticle 2016 Sio, T. T.; Lin, H. K.; Shi, Q.; Gunn, G. B.; Cleeland, C. S.; Lee, J. J.; Hernandez, M.; Blanchard, P.; Thaker, N. G.; Phan, J.; Rosenthal, D. I.; Garden, A. S.; Morrison, W. H.; Fuller, C. D.; Mendoza, T. R.; Mohan, R.; Wang, X. S.; Frank, S. J.
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab journalArticle 2016 Lassau, N.; Coiffier, B.; Kind, M.; Vilgrain, V.; Lacroix, J.; Cuinet, M.; Taieb, S.; Aziza, R.; Sarran, A.; Labbe-Devilliers, C.; Gallix, B.; Lucidarme, O.; Ptak, Y.; Rocher, L.; Caquot, L. M.; Chagnon, S.; Marion, D.; Luciani, A.; Feutray, S.; Uzan-Augui, J.; Benatsou, B.; Bonastre, J.; Koscielny, S.
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial journalArticle 2016 Loi, S.; Dafni, U.; Karlis, D.; Polydoropoulou, V.; Young, B. M.; Willis, S.; Long, B.; de Azambuja, E.; Sotiriou, C.; Viale, G.; Ruschoff, J.; Piccart, M. J.; Dowsett, M.; Michiels, S.; Leyland-Jones, B.
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers journalArticle 2016 Fumagalli, D.; Wilson, T. R.; Salgado, R.; Lu, X.; Yu, J.; O'Brien, C.; Walter, K.; Huw, L. Y.; Criscitiello, C.; Laios, I.; Jose, V.; Brown, D. N.; Rothe, F.; Maetens, M.; Zardavas, D.; Savas, P.; Larsimont, D.; Piccart-Gebhart, M. J.; Michiels, S.; Lackner, M. R.; Sotiriou, C.; Loi, S.
Variation in rates of breast cancer surgery: A national analysis based on French Hospital Episode Statistics journalArticle 2016 Rococo, E.; Mazouni, C.; Or, Z.; Mobillion, V.; Koon Sun Pat, M.; Bonastre, J.
[Radiotherapy for nasopharyngeal carcinoma] journalArticle 2016 Maingon, P.; Blanchard, P.; Bidault, F.; Calmels, L.
Towards understanding the breast cancer epigenome: a comparison of genome-wide DNA methylation and gene expression data journalArticle 2016 Singhal, S. K.; Usmani, N.; Michiels, S.; Metzger-Filho, O.; Saini, K. S.; Kovalchuk, O.; Parliament, M.
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group journalArticle 2016 Denkert, C.; Wienert, S.; Poterie, A.; Loibl, S.; Budczies, J.; Badve, S.; Bago-Horvath, Z.; Bane, A.; Bedri, S.; Brock, J.; Chmielik, E.; Christgen, M.; Colpaert, C.; Demaria, S.; Van den Eynden, G.; Floris, G.; Fox, S. B.; Gao, D.; Ingold Heppner, B.; Kim, S. R.; Kos, Z.; Kreipe, H. H.; Lakhani, S. R.; Penault-Llorca, F.; Pruneri, G.; Radosevic-Robin, N.; Rimm, D. L.; Schnitt, S. J.; Sinn, B. V.; Sinn, P.; Sirtaine, N.; O'Toole, S. A.; Viale, G.; Van de Vijver, K.; de Wind, R.; von Minckwitz, G.; Klauschen, F.; Untch, M.; Fasching, P. A.; Reimer, T.; Willard-Gallo, K.; Michiels, S.; Loi, S.; Salgado, R.
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease journalArticle 2016 Marthey, L.; Mateus, C.; Mussini, C.; Nachury, M.; Nancey, S.; Grange, F.; Zallot, C.; Peyrin-Biroulet, L.; Rahier, J. F.; Bourdier de Beauregard, M.; Mortier, L.; Coutzac, C.; Soularue, E.; Lanoy, E.; Kapel, N.; Planchard, D.; Chaput, N.; Robert, C.; Carbonnel, F.
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer journalArticle 2016 Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P.
Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer journalArticle 2016 Brambilla, E.; Le Teuff, G.; Marguet, S.; Lantuejoul, S.; Dunant, A.; Graziano, S.; Pirker, R.; Douillard, J. Y.; Le Chevalier, T.; Filipits, M.; Rosell, R.; Kratzke, R.; Popper, H.; Soria, J. C.; Shepherd, F. A.; Seymour, L.; Tsao, M. S.
Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer journalArticle 2016 McKeever, M. R.; Sio, T. T.; Gunn, G. B.; Holliday, E. B.; Blanchard, P.; Kies, M. S.; Weber, R. S.; Frank, S. J.
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial journalArticle 2016 Blanchard, P.; Faivre, L.; Lesaunier, F.; Salem, N.; Mesgouez-Nebout, N.; Deniau-Alexandre, E.; Rolland, F.; Ferrero, J. M.; Houede, N.; Mourey, L.; Theodore, C.; Krakowski, I.; Berdah, J. F.; Baciuchka, M.; Laguerre, B.; Davin, J. L.; Habibian, M.; Culine, S.; Laplanche, A.; Fizazi, K.
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene journalArticle 2016 van Kempen, L. C.; Redpath, M.; Elchebly, M.; Klein, K. O.; Papadakis, A. I.; Wilmott, J. S.; Scolyer, R. A.; Edqvist, P. H.; Ponten, F.; Schadendorf, D.; van Rijk, A. F.; Michiels, S.; Dumay, A.; Helbling-Leclerc, A.; Dessen, P.; Wouters, J.; Stass, M.; Greenwood, C. M.; Ghanem, G. E.; van den Oord, J.; Feunteun, J.; Spatz, A.
Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy journalArticle 2016 Chargari, C.; Mazeron, R.; Dunant, A.; Gouy, S.; Petit, C.; Maroun, P.; Uzan, C.; Annede, P.; Bentivegna, E.; Balleyguier, C.; Genestie, C.; Pautier, P.; Leary, A.; Lhomme, C.; Deutsch, E.; Morice, P.; Haie-Meder, C.
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis journalArticle 2016 Ma, X.; Le Teuff, G.; Lacas, B.; Tsao, M. S.; Graziano, S.; Pignon, J. P.; Douillard, J. Y.; Le Chevalier, T.; Seymour, L.; Filipits, M.; Pirker, R.; Janne, P. A.; Shepherd, F. A.; Brambilla, E.; Soria, J. C.; Hainaut, P.; Group, L. A. C. E. Bio Collaborative
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial journalArticle 2016 Jovelet, C.; Ileana, E.; Le Deley, M. C.; Motte, N.; Rosellini, S.; Romero, A.; Lefebvre, C.; Pedrero, M.; Pata-Merci, N.; Droin, N.; Deloger, M.; Massard, C.; Hollebecque, A.; Ferte, C.; Boichard, A.; Postel-Vinay, S.; Ngo-Camus, M.; De Baere, T.; Vielh, P.; Scoazec, J. Y.; Vassal, G.; Eggermont, A.; Andre, F.; Soria, J. C.; Lacroix, L.
Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis journalArticle 2016 Chopra, H.; Arangalage, D.; Bouleti, C.; Zarka, S.; Fayard, F.; Chillon, S.; Laissy, J. P.; Henry-Feugeas, M. C.; Steg, P. G.; Vahanian, A.; Ou, P.
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer journalArticle 2016 Michiels, S.; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; Buyse, M.; Piccart, M.